teladoc glp-1 receptor agonists weight management diabetes treatments agonist Ozempic vs Tirzepatide Patients seeking new weight loss

These medications mimic GLP-1s effects, reducing hunger and calorie intake, which supports effective and sustained weight loss

GIP(3-30)NH 2 has been infused in both healthy individuals (75), patients with type 1 diabetes (77), type 2 diabetes (78, p

They are now commonly used when: Metformin alone is no longer enough Weight gain is contributing to worsening glucose control There is a need to minimise hypoglycaemia risk Someone has existing cardiovascular disease or multiple risk factors For many people, GLP-1 therapy can delay or reduce the need for insulin, or allow insulin doses to be kept lower and safer

Eosinophil-rich granulomatous panniculitis caused by exenatide injection